Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

3PM3

Bovine trypsin variant X(tripleIle227) in complex with small molecule inhibitor

Summary for 3PM3
Entry DOI10.2210/pdb3pm3/pdb
Related1V2K 3PLB 3PLK 3PLP
Related PRD IDPRD_001046
DescriptorCationic trypsin, CALCIUM ION, N-(benzylsulfonyl)-O-tert-butyl-D-seryl-N-(4-carbamimidoylbenzyl)glycinamide, ... (6 entities in total)
Functional Keywordstrypsin-like serine protease, hydrolase, protein binding, none, duodenum, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor
Biological sourceBos taurus (bovine)
Cellular locationSecreted, extracellular space: P00760
Total number of polymer chains1
Total formula weight24392.43
Authors
Tziridis, A.,Neumann, P.,Kolenko, P.,Stubbs, M.T. (deposition date: 2010-11-16, release date: 2011-12-07, Last modification date: 2024-10-30)
Primary citationTziridis, A.,Rauh, D.,Neumann, P.,Kolenko, P.,Menzel, A.,Brauer, U.,Ursel, C.,Steinmetzer, P.,Sturzebecher, J.,Schweinitz, A.,Steinmetzer, T.,Stubbs, M.T.
Correlating structure and ligand affinity in drug discovery: a cautionary tale involving second shell residues.
Biol.Chem., 395:891-903, 2014
Cited by
PubMed Abstract: A high-resolution crystallographic structure determination of a protein-ligand complex is generally accepted as the 'gold standard' for structure-based drug design, yet the relationship between structure and affinity is neither obvious nor straightforward. Here we analyze the interactions of a series of serine proteinase inhibitors with trypsin variants onto which the ligand-binding site of factor Xa has been grafted. Despite conservative mutations of only two residues not immediately in contact with ligands (second shell residues), significant differences in the affinity profiles of the variants are observed. Structural analyses demonstrate that these are due to multiple effects, including differences in the structure of the binding site, differences in target flexibility and differences in inhibitor binding modes. The data presented here highlight the myriad competing microscopic processes that contribute to protein-ligand interactions and emphasize the difficulties in predicting affinity from structure.
PubMed: 25003390
DOI: 10.1515/hsz-2014-0158
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.53 Å)
Structure validation

226707

PDB entries from 2024-10-30

PDB statisticsPDBj update infoContact PDBjnumon